日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium

CAR-T细胞疗法治疗大B细胞淋巴瘤失败后双特异性抗体的疗效:来自ABC联盟的研究结果

Melody, Megan; Grover, Natalie; Franco, Stephanie; Romancik, Jason; Cortese, Matthew; Moyo, Tamara K; Bhansali, Rahul S; Ollila, Thomas; Kenkre, Vaishalee; Fitzgerald, Lindsey; Hess, Brian; Matasar, Matt; Shouse, Geoffrey; Annunzio, Kaitlin; Herr, Megan M; Davis, James A; Jesme, Christy; Pelcovits, Ari; Moreira, Jonathan; Ma, Shuo; Winter, Jane N; Lin, Adam; Danilov, Alexey; Roy, Ishan; Barta, Stefan K; Gordon, Leo I; Stephens, Deborah; Cohen, Jonathon B; Epperla, Narendranath; Karmali, Reem

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium

CAR-T方案作为侵袭性B细胞淋巴瘤二线、三线、四线及以上治疗的疗效:来自ABC联盟的真实世界证据

Wang, John S; Ellsworth, Brandon L; Melody, Megan; Epperla, Narendranath; Stephens, Deborah; Romancik, Jason; Cortese, Matthew; Bhansali, Rahul; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Matasar, Matthew; Herr, Megan M; Davis, James; Jesme, Christy; Pelcovits, Ari R; Moreira, Jonathan; Lin, Adam Y; Ma, Shuo; Winter, Jane N; Danilov, Alexey V; Shah, Nirav N; Barta, Stefan K; Cohen, Jonathon B; Gordon, Leo I; Grover, Natalie; Karmali, Reem

Defining 'Intention' in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy

嵌合抗原受体T细胞疗法中“意向性治疗”生存结果的“意向性”定义

Milrod, Charles J; Steuer, Rebecca; Pelcovits, Ari

Prebiopsy Steroids and Diagnostic Yield in Patients With Diffuse Large B-Cell Lymphoma

活检前使用类固醇对弥漫性大B细胞淋巴瘤患者诊断率的影响

Madireddy, Sathwik; Pou, Sovijja; Mandi, Kaavya; Pan, Kelly; Friefeld, Alex; Ding, Huang He; Raker, Christina; Terada, Ross; Milrod, Charles J; Pelcovits, Ari

Topology and kinetic pathways of colloidosome assembly and disassembly

胶体囊泡组装和解体的拓扑结构和动力学途径

Adkins, Raymond; Robaszewski, Joanna; Shin, Seungwoo; Brauns, Fridtjof; Jia, Leroy; Khanra, Ayantika; Sharma, Prerna; Pelcovits, Robert A; Powers, Thomas R; Dogic, Zvonimir

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART

CAR-T细胞疗法治疗侵袭性淋巴瘤合并自身免疫性疾病患者的真实世界疗效

Altomare, Nicole J; Herr, Megan M; Nair, Nisha M; Stephens, Deborah M; Cohen, Jonathon B; Epperla, Narendranath; Cortese, Matthew; Bhansali, Rahul; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Davis, James A; Jesme, Christy; Pelcovits, Ari; Moreira, Jonathan; Lin, Adam; Ma, Shuo; Winter, Jane N; Danilov, Alexey; Barta, Stefan K; Gordon, Leo I; Romancik, Jason; Grover, Natalie S; Karmali, Reem

Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient

特克利司他单抗治疗在一名难治性多发性骨髓瘤患者中诱发进行性多灶性白质脑病

Arvanitis, Panos; Farmakiotis, Dimitrios; Pelcovits, Ari

Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects

免疫检查点抑制剂在晚期和复发/难治性霍奇金淋巴瘤中的应用:现状与展望

Milrod, Charles J; Pelcovits, Ari; Ollila, Thomas A

Sézary syndrome associated vitiligo-like leukoderma in type V skin: Report of a case and review of the literature

Sézary综合征伴白癜风样白斑(V型皮肤):病例报告及文献复习

Mirza, Fatima N; Olszewski, Adam J; Pelcovits, Ari R; DiMarco, Christopher; Firoz, Elnaz F

Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study

伊沙佐米、口服节拍式环磷酰胺和地塞米松一线治疗多发性骨髓瘤:布朗大学肿瘤协作组 II 期研究

Pelcovits, Ari; Barth, Peter; Reagan, John L; Olszewski, Adam J; Rosati, Vallerie; Wood, Roxanne; Sturtevant, Ashlee; Winer, Eric S